Skip to main content
CML-CP: BCR-ABL1 transcript doubling time predicts TFR failure after imatinib discontinuation
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
CML-CP: BCR-ABL1 transcript doubling time predicts TFR failure after imatinib discontinuation
User login
Username
Password
Reset your password
Type
Lead
score
Edit Tags